Real Nutriceutical Group Limited provided consolidated earnings guidance for the six months ended June 30, 2017. The board of directors of the company announced that based on the Board's preliminary assessment of the unaudited consolidated management accounts of the Group for the six months ended 30 June 2017 and the information currently available to the Group, the company is expected to record a decrease in the unaudited profit of the Group for first half of 2017 of approximately 90% as compared to the unaudited profit of approximately RMB 68 million for the six months ended 30 June 2016. Such decrease in profit for first half of 2017 was primarily attributable to an approximately 30% decrease in the revenue of the company for first half of 2017 mainly as a result of a decrease in the revenue of the Group's major products, namely health supplement and beverage products due to the general weakness in China consumer markets; and a decrease in the gross profit margin for first half of 2017 of approximately 8.3% as compared to a gross profit margin of 64.5% for first half of 2016 due to a change in the sales mix and an increase in the production costs.